• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Provide better postoperative pain outcomes for your patients with MAXIGESIC® IV (paracetamol 1000mg and ibuprofen (as sodium dihydrate) 300mg in 100mL, solution for infusion).

MAXIGESIC® IV provides effective combination analgesic therapy with the administration of a single formulation in postoperative patients unable to receive oral analgesics:

· Superior pain relief than paracetamol IV or ibuprofen IV alone

· Reduced opioid consumption compared with paracetamol IV and ibuprofen IV

· No compromise in safety compared with paracetamol IV and ibuprofen IV

· Simple opioid-free hospital-to-home transition

Share

Key dates

  • Abstract Submissions Open

    16 March

  • Early Bird Registrations Open

    24 April

  • Abstract Submissions Close

    1 July

  • Abstract Acceptance Notification

    Late August

  • Volunteer Applications Close

    26 August

  • Presenter Acceptance Deadline

    Early September

  • Early Bird Registration Deadline

    7 September

  • Presenter Registration Deadline

    Late September

  • Standard Registration Deadline

    6 November

Related